• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阻塞性睡眠呼吸暂停中的血浆脑钠肽

Plasma brain natriuretic peptide in obstructive sleep apnea.

作者信息

Svatikova Anna, Shamsuzzaman Abu S, Wolk Robert, Phillips Bradley G, Olson Lyle J, Somers Virend K

机构信息

Mayo Clinic Foundation, 200 First Street SW, Rochester, MH 55905, USA.

出版信息

Am J Cardiol. 2004 Aug 15;94(4):529-32. doi: 10.1016/j.amjcard.2004.05.010.

DOI:10.1016/j.amjcard.2004.05.010
PMID:15325948
Abstract

We compared brain natriuretic peptide (BNP) levels in patients with obstructive sleep apnea (OSA) with and without cardiovascular disease to BNP in healthy control subjects. OSA was not associated with increased plasma BNP or atrial natriuretic peptide (ANP) in otherwise healthy subjects during wakefulness. Untreated OSA increased ANP overnight, and ANP levels decreased with treatment of OSA. However, OSA did not elicit acute overnight changes in BNP, either in normal subjects or in patients with coexisting cardiovascular disease (including chronic heart failure).

摘要

我们将患有和未患有心血管疾病的阻塞性睡眠呼吸暂停(OSA)患者的脑钠肽(BNP)水平与健康对照者的BNP水平进行了比较。在清醒状态下,对于其他方面健康的受试者,OSA与血浆BNP或心房钠尿肽(ANP)升高无关。未经治疗的OSA会使ANP在夜间升高,而ANP水平会随着OSA的治疗而降低。然而,无论是在正常受试者还是在合并心血管疾病(包括慢性心力衰竭)的患者中,OSA均未引起BNP的急性夜间变化。

相似文献

1
Plasma brain natriuretic peptide in obstructive sleep apnea.阻塞性睡眠呼吸暂停中的血浆脑钠肽
Am J Cardiol. 2004 Aug 15;94(4):529-32. doi: 10.1016/j.amjcard.2004.05.010.
2
Natriuretic peptides in sleep apnea.睡眠呼吸暂停中的利钠肽
Am J Cardiol. 2005 Mar 1;95(5):708. doi: 10.1016/j.amjcard.2004.10.061.
3
The nocturnal secretion of cardiac natriuretic peptides during obstructive sleep apnoea and its response to therapy with nasal continuous positive airway pressure.阻塞性睡眠呼吸暂停期间心钠素的夜间分泌及其对经鼻持续气道正压通气治疗的反应
J Sleep Res. 1998 Sep;7(3):199-207. doi: 10.1046/j.1365-2869.1998.00109.x.
4
Changes of circulating atrial natriuretic peptide and antidiuretic hormone in obstructive sleep apnea syndrome.阻塞性睡眠呼吸暂停综合征患者循环心房利钠肽和抗利尿激素的变化
Respiration. 1992;59(3):164-8. doi: 10.1159/000196049.
5
Atrial natriuretic peptide levels and pulmonary artery pressure awake, at exercise and asleep in obstructive sleep apnoea syndrome.阻塞性睡眠呼吸暂停综合征患者清醒、运动及睡眠时的心房利钠肽水平与肺动脉压力
J Sleep Res. 1999 Sep;8(3):205-10. doi: 10.1046/j.1365-2869.1999.00151.x.
6
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in heart failure.心力衰竭时心房利钠肽和脑利钠肽的异常节律性振荡
Clin Sci (Lond). 2003 Mar;104(3):303-12. doi: 10.1042/CS20020138.
7
Nocturnal oxygen therapy prevents progress of congestive heart failure with central sleep apnea.夜间氧疗可预防伴有中枢性睡眠呼吸暂停的充血性心力衰竭的进展。
Int J Cardiol. 2007 Feb 14;115(3):354-60. doi: 10.1016/j.ijcard.2006.03.018. Epub 2006 Jun 23.
8
Abnormal rhythmic oscillations of atrial natriuretic peptide and brain natriuretic peptide in chronic renal failure.慢性肾衰竭时心房利钠肽和脑利钠肽的异常节律性振荡
Clin Sci (Lond). 2006 Apr;110(4):491-501. doi: 10.1042/CS20050336.
9
Atrial natriuretic peptide release during sleep in patients with obstructive sleep apnoea before and during treatment with nasal continuous positive airway pressure.阻塞性睡眠呼吸暂停患者在接受鼻持续气道正压通气治疗前及治疗期间睡眠时心房利钠肽的释放情况。
Clin Sci (Lond). 1989 Oct;77(4):407-11. doi: 10.1042/cs0770407.
10
Natriuretic peptide response to dynamic exercise in patients with atrial fibrillation.心房颤动患者对动态运动的利钠肽反应。
Int J Cardiol. 2005 Oct 20;105(1):31-9. doi: 10.1016/j.ijcard.2004.10.046.

引用本文的文献

1
Sympathetic overactivity and nocturnal diuresis in obstructive sleep apnea alter the response to hypertension therapy.阻塞性睡眠呼吸暂停中的交感神经过度活跃和夜间多尿会改变对高血压治疗的反应。
Clin Hypertens. 2024 Jun 1;30(1):14. doi: 10.1186/s40885-024-00272-x.
2
The role of 3D speckle tracking echocardiography in the diagnosis of obstructive sleep apnea and its severity.三维斑点追踪超声心动图在阻塞性睡眠呼吸暂停及其严重程度诊断中的作用。
Sci Rep. 2022 Dec 26;12(1):22347. doi: 10.1038/s41598-022-26940-2.
3
Silencing MR-1 Protects against Myocardial Injury Induced by Chronic Intermittent Hypoxia by Targeting Nrf2 through Antioxidant Stress and Anti-Inflammation Pathways.
沉默 MR-1 通过抗氧化应激和抗炎途径靶向 Nrf2 保护慢性间歇性低氧诱导的心肌损伤。
J Healthc Eng. 2022 Jan 3;2022:3471447. doi: 10.1155/2022/3471447. eCollection 2022.
4
Endothelial dysfunction in obstructive sleep apnea patients.阻塞性睡眠呼吸暂停患者的内皮功能障碍。
Sleep Breath. 2022 Mar;26(1):231-242. doi: 10.1007/s11325-021-02382-4. Epub 2021 May 7.
5
Effect of Obstructive Sleep Apnea and Positive Airway Pressure Therapy on Cardiac Remodeling as Assessed by Cardiac Biomarker and Magnetic Resonance Imaging in Nonobese and Obese Adults.非肥胖和肥胖成年人中,通过心脏生物标志物和磁共振成像评估阻塞性睡眠呼吸暂停及正压通气治疗对心脏重构的影响。
Hypertension. 2021 Mar 3;77(3):980-992. doi: 10.1161/HYPERTENSIONAHA.120.15882. Epub 2021 Jan 19.
6
Evaluation of right ventricular performance and impact of continuous positive airway pressure therapy in patients with obstructive sleep apnea living at high altitude.评估高原地区阻塞性睡眠呼吸暂停患者的右心室功能和持续气道正压通气治疗的影响。
Sci Rep. 2020 Nov 19;10(1):20186. doi: 10.1038/s41598-020-71584-9.
7
Hematological indices as simple, inexpensive and practical severity markers of obstructive sleep apnea syndrome: a meta-analysis.血液学指标作为阻塞性睡眠呼吸暂停综合征简单、廉价且实用的严重程度标志物:一项荟萃分析。
J Thorac Dis. 2018 Dec;10(12):6509-6521. doi: 10.21037/jtd.2018.10.105.
8
Biomarkers in Sleep Apnea and Heart Failure.睡眠呼吸暂停与心力衰竭中的生物标志物
Curr Heart Fail Rep. 2017 Aug;14(4):284-300. doi: 10.1007/s11897-017-0339-7.
9
The effect of surgical and non-surgical weight loss on N-terminal pro-B-type natriuretic peptide and its relation to obstructive sleep apnea and pulmonary function.手术和非手术减肥对N端前B型利钠肽的影响及其与阻塞性睡眠呼吸暂停和肺功能的关系。
BMC Res Notes. 2016 Sep 13;9(1):440. doi: 10.1186/s13104-016-2241-x.
10
Dynamic cycling in atrial size and flow during obstructive apnoea.阻塞性呼吸暂停期间心房大小和血流的动态变化。
Open Heart. 2016 Feb 23;3(1):e000348. doi: 10.1136/openhrt-2015-000348. eCollection 2016.